That headline is potentially referring to a real medication risk, but it is far too vague to act on without knowing which tablets it means.
One important example is JAK inhibitors such as tofacitinib, baricitinib, and upadacitinib. The FDA requires prominent warnings for these medicines about increased risks of serious cardiovascular events, including heart attack and stroke, as well as blood clots and death. The risk is particularly important to discuss in people with cardiovascular risk factors or a history of smoking, heart attack, stroke, or blood clots.
U
U.S. Food and Drug Administration
+1
But many medications do not increase clotting risk, and some tablets—such as warfarin, apixaban, and other anticoagulants—are actually prescribed specifically to prevent blood clots.
N
nhs.uk
+1
🚨 Don’t stop a prescribed medicine because of this headline
Stopping some medicines suddenly can itself be dangerous. The correct response is to identify the exact medication and dose and then check its known risks and your individual risk factors.
If you give me the name of the tablets (or upload a photo of the package), I can tell you:
whether they really carry a blood-clot or heart-attack warning,
how significant the risk is,
who is most vulnerable, and
what symptoms require emergency attention.
U
N
Sources
